Review article · 2026 · Open access

Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair

Wei Ji, Hayriye Akel Bilgiç, Maarten van den Berge, Huib A.M. Kerstjens, Gert Folkerts, Reinoud Gosens, Saskia Braber

Pharmacological Reviews, 78(3), 100131 · Published 19 March 2026 · DOI 10.1016/j.pharmr.2026.100131

Open full textCite this paper

In brief

“Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair” is a 2026 review article by Wei Ji and 6 co-authors, published in Pharmacological Reviews. OpenAlex counts 9 citations as of 17 November 2026, which puts it in the top 2% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmacological Reviews.

Citations
9
Most cited in
2026 (9)
Field-weighted impact
9.50
References
412
Authors
7

Abstract

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by chronic respiratory symptoms and persistent, often progressive, loss of lung function. Patients, particularly those with severe disease, frequently experience exacerbations triggered by viral and bacterial infections. Exacerbations are closely linked to the rapid decline in lung function, accounting for more than 50% of the accelerated loss over the lifetime of a patient with COPD. Airway epithelial cells play a central role in the development of COPD exacerbations. As the first line of defense, these cells form tight intercellular junctions, creating a protective barrier against pathogens and producing mucus and antimicrobial peptides to eliminate bacteria and viruses. Upon pathogen recognition via pattern recognition receptors, epithelial cells initiate inflammatory responses by releasing cytokines and chemokines that recruit immune cells. This inflammation can become dysregulated in COPD, contributing to tissue damage and exacerbation severity. Furthermore, airway epithelial cells are particularly important in promoting lung repair and restoring homeostasis. They modulate inflammation resolution, promote extracellular matrix remodeling, and support lung regeneration. In COPD, chronic inflammation and repeated exacerbations impair epithelial function, disrupt repair mechanisms, and hinder lung regeneration, contributing to irreversible damage. This review highlights the crucial role of airway epithelial cells in COPD exacerbations, focusing on their regulatory functions in maintaining barrier integrity, managing inflammation and promoting epithelial lung repair. Moreover, current and future therapeutic strategies aimed at enhancing epithelial barrier function, controlling airway inflammation, and supporting lung recovery and regeneration are discussed, highlighting key directions for future investigation. SIGNIFICANCE STATEMENT: Chronic obstructive pulmonary disease exacerbations represent a pharmacologically actionable period characterized by epithelial barrier disruption, dysregulated inflammation, and impaired repair. This review positions airway epithelial cells as central orchestrators of these processes, regulating host defense, immune interactions, and regenerative responses. By targeting epithelial dysfunction during exacerbations, this review highlights the potential therapies that go beyond symptom relief and support lung repair and modify disease progression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ji, W., Bilgiç, H. A., van den Berge, M., Kerstjens, H. A., Folkerts, G., Gosens, R., & Braber, S. (2026). Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair. Pharmacological Reviews, 78(3), 100131. https://doi.org/10.1016/j.pharmr.2026.100131

MLA 9

Ji, Wei, et al. “Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair.” Pharmacological Reviews, vol. 78, no. 3, 2026, p. 100131. https://doi.org/10.1016/j.pharmr.2026.100131.

Chicago

Ji, Wei, Hayriye Akel Bilgiç, Maarten van den Berge, Huib A.M. Kerstjens, Gert Folkerts, Reinoud Gosens, and Saskia Braber. 2026. “Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair.” Pharmacological Reviews 78 (3): 100131. https://doi.org/10.1016/j.pharmr.2026.100131.

Harvard

Ji, W. et al. (2026) ‘Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair’, Pharmacological Reviews, 78(3), p. 100131. doi:10.1016/j.pharmr.2026.100131.

IEEE

W. Ji et al., “Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair,” Pharmacological Reviews, vol. 78, no. 3, p. 100131, 2026, doi: 10.1016/j.pharmr.2026.100131.

BibTeX

@article{ji2026epithelial,
  title     = {{Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair}},
  author    = {Ji, Wei and Bilgiç, Hayriye Akel and van den Berge, Maarten and Kerstjens, Huib A.M. and Folkerts, Gert and Gosens, Reinoud and Braber, Saskia},
  journal   = {Pharmacological Reviews},
  year      = {2026},
  volume    = {78},
  number    = {3},
  pages     = {100131},
  doi       = {10.1016/j.pharmr.2026.100131},
  url       = {https://doi.org/10.1016/j.pharmr.2026.100131}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research

  • chronic obstructive pulmonary disease
  • COPD exacerbations
  • airway epithelial cells
  • epithelial barrier function
  • lung repair
  • lung regeneration
  • airway inflammation
  • pattern recognition receptors

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Ji, W., Bilgiç, H. A., van den Berge, M., Kerstjens, H. A., Folkerts, G., Gosens, R., & Braber, S. (2026). Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair. Pharmacological Reviews, 78(3), 100131. https://doi.org/10.1016/j.pharmr.2026.100131

How many times has this paper been cited?

9 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmacological Reviews: sign in and open the full text from this page.

Who wrote this paper?

Wei Ji, Hayriye Akel Bilgiç, Maarten van den Berge, Huib A.M. Kerstjens, Gert Folkerts, Reinoud Gosens, Saskia Braber.

What is the DOI of this paper?

10.1016/j.pharmr.2026.100131, permanently at https://doi.org/10.1016/j.pharmr.2026.100131. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.